Abstract
Highly conserved PenI-type class A β-lactamase in pathogenic members of Burkholderia species can evolve to extended-spectrum β-lactamase (ESBL), which exhibits hydrolytic activity toward third-generation cephalosporins, while losing its activity toward the original penicillin substrates. We describe three single-amino-acid-substitution mutations in the ArgS arginine-tRNA synthetase that confer extra antibiotic tolerance protection to ESBL-producing Burkholderia thailandensis. This pathway can be exploited to evade antibiotic tolerance induction in developing therapeutic measures against Burkholderia species, targeting their essential aminoacyl-tRNA synthetases.
Original language | English |
---|---|
Article number | e02252-19 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 64 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2020 Jun |
Bibliographical note
Funding Information:This work was supported by grants NRF-2018R1A2B2006456, 2018M3A9F3055923, and 2015M3C9A4053393 from the National Research Foundation (NRF) of the Republic of Korea. Additional support was provided by grant 2016R1A6A3A11935950 for research fellows from the NRF of the Republic of Korea to H.Y.
Publisher Copyright:
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Keywords
- Antibiotic tolerance
- ArgS
- Arginine-tRNA synthetase
- Stringent response
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases